Royal Bank Of Canada upgraded shares of KP Tissue Inc (TSE:KPT) from a sector perform rating to an outperform rating in a report issued on Monday, StockTargetPrices.com reports. They currently have C$17.00 price objective on the stock, up from their prior price objective of C$15.00.
A number of other research analysts also recently commented on KPT. Desjardins raised shares of KP Tissue from a hold rating to a buy rating and raised their target price for the company from C$13.50 to C$15.00 in a research report on Thursday, August 11th. Scotiabank raised shares of KP Tissue from a sector perform rating to an outperform rating and raised their target price for the company from C$14.00 to C$16.50 in a research report on Thursday, August 11th. TD Securities reaffirmed a buy rating and issued a C$15.00 price objective on shares of KP Tissue in a research report on Thursday, August 11th. Finally, CIBC lifted their price objective on shares of KP Tissue from C$15.00 to C$16.00 in a research report on Friday, August 12th. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of C$16.21.
Shares of KP Tissue (TSE:KPT) opened at 14.80 on Monday. The firm has a 50-day moving average of $14.24 and a 200 day moving average of $13.41. KP Tissue has a 1-year low of $9.70 and a 1-year high of $14.84. The company’s market capitalization is $134.55 million.
About KP Tissue